Chimerix to Present at the 37th Annual J.P. Morgan Healthcare Conference
DURHAM, N.C., Jan. 04, 2019 (GLOBE NEWSWIRE) — Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing novel antivirals to address life-threatening viral infections, […]
Biogen and C4 Therapeutics Enter into Strategic Collaboration to Discover and Develop Potential New Treatments for Neurological Conditions
C4T’s targeted protein degradation platform provides a novel approach to neuroscience drug discovery and development, complementing Biogen’s broader research and […]
Biogen and Skyhawk Therapeutics Announce Agreement to Develop Novel Small Molecule RNA Splicing Modifiers for Neurological Disease Targets
Biogen made a one-time upfront $74 million payment to Skyhawk for research services and an exclusive license to therapeutic candidates […]
Result of General Meeting
Summit Therapeutics plc(“Summit Therapeutics” or the “Company”) Result of General Meeting Oxford, UK, and Cambridge, MA, US, 4 January 2019 […]
Saia Names Holzgrefe President and COO
JOHNS CREEK, Ga., Jan. 04, 2019 (GLOBE NEWSWIRE) — Saia, Inc. (NASDAQ: SAIA), a leading transportation provider offering multi-regional less-than-truckload […]
Idera Pharmaceuticals to Present at the 37th Annual J.P. Morgan Healthcare Conference
EXTON, Pa., Jan. 04, 2019 (GLOBE NEWSWIRE) — Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) today announced that the company will present […]
TSX News -
Colliers International Completes Acquisition of Market Leader in Virginia
Acquisition strengthens U.S. platform in important Mid-Atlantic Region TORONTO and NORFOLK, Va., Jan. 04, 2019 (GLOBE NEWSWIRE) — Leading global […]
Weather Telematics Inc. to Exhibit at CES 2019 in Las Vegas
TORONTO and OTTAWA, Ontario, Jan. 04, 2019 (GLOBE NEWSWIRE) — Internet of Things Inc. (TSX VENTURE: ITT; OTC: INOTF; FRANKFURT: […]
Resonant Inc. to Present at the 21st Annual Needham Growth Conference
GOLETA, Calif., Jan. 04, 2019 (GLOBE NEWSWIRE) — Resonant Inc. (NASDAQ: RESN), a leader in transforming the way radio frequency, […]
Emergent BioSolutions Announces Daniel J. Abdun-Nabi to Retire as CEO; Robert G. Kramer, Sr. to Become President and CEO
GAITHERSBURG, Md., Jan. 04, 2019 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE: EBS) today announced that its CEO Daniel J. […]
